Zogenix Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Zogenix's estimated annual revenue is currently $24.1M per year.
- Zogenix received $288.9M in venture funding in October 2017.
- Zogenix's estimated revenue per employee is $137,829
- Zogenix's total funding is $264.3M.
- Zogenix has 175 Employees.
- Zogenix grew their employee count by 19% last year.
- Zogenix currently has 30 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Online Review||Pricing|
What Is Zogenix?
Zogenix is committed to developing and commercializing therapies for central nervous system disorders that address specific clinical needs for people living with rare diseases and other CNS disorders who need innovative treatment alternatives to improve their daily functioning. We seek best-in-class leaders with scientific, medical and commercial expertise in the therapeutic areas in which we participate. By sharing a collective passion for making a difference in the lives of patients we serve, our unique company culture thrives through the principles of ethical decision making, open communication and collaboration.keywords:Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
EMERYVILLE, Calif., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing ...
“This transaction advances Zogenix's mission to become a leading rare disease pharmaceutical company by adding MT1621 to our pipeline of ...
Shares of Zogenix (NASDAQ: ZGNX) closed Monday about 8.5% lower, a decline precipitated by the biotech's announcement that it plans to ...
|2006-08-29||$60.0M||A||Clarus Ventures, Domain Associates LLC||Article|
|2006-09-28||$60.0M||Undisclosed||Clarus Ventures, Domain Associates||Article|
|2008-01-10||$18.0M||Undisclosed||Abingworth Management Ltd||Article|
|2008-07-29||$18.0M||Undisclosed||Oxford Finance Corporation, CIT Healthcare LLC||Article|
|2009-09-24||$51.0M||Undisclosed||Clarus Ventures, Domain Associates||Article|
|2009-12-08||$35.0M||Undisclosed||Chicago Growth Partners, Clarus Ventures||Article|
|2010-07-14||$50.0M||Undisclosed||Oxford Finance Corporation||Article|
|2015-07-31||$98.3M||Undisclosed||Leerink Partners LLC||Article|
|2017-10-04||$288.9M||Undisclosed||Leerink Partners LLC||Article|
Zogenix Executive Hires
|2006-10-17||J.D. Haldeman||VP Commercial/Corp Communications||Article|
|2007-06-08||David Nassif||EVP/Chief Financial Officer||Article|
|2008-04-18||Cynthia Robinson||Chief Development Officer||Article|
|2010-03-02||Ann D. Rhoads||CFO||Article|
|2013-12-18||Bradley S. Galer||EVP/Chief Medical Officer.||Article|
|2015-07-07||Gail M. Farfel||Executive Vice President/Chief Development Officer||Article|